We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NNOX:NASDAQNANO-X IMAGING LTD analysis

Data as of Oct 15, 2026 - not real-time

Latest price
$0.51
Risk: high
9/10High risk

Summary

Nano-X Imaging Ltd. is priced at $0.5107 and its moving averages line up in bearish order, the shorter trailing the longer. It has lost 35.0% over the past 30 days. Momentum indicators put RSI at 28.6 (oversold) with MACD reading bearish. The recent range runs from support at $0.5000 up to resistance at $0.8100.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 709.3% above the current quote. Revenue is growing at 36.7%.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 99.1%, a beta of 1.43 and a maximum drawdown of 88.8%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top market events

  • Nano-X Imaging NASDAQ:NNOX reported second-quarter 2026 revenue growth driven by its teleradiology, health IT and AI...
  • On September 9, Nano-X Imaging NASDAQ:NNOX held its second-quarter earnings call, and the message was blunt: growth is...
  • Nano X Imaging Ltd NNOX reports strong top-line growth driven by teleradiology services, while navigating a $40.

Market outlook

Short term

< 1 year

Neutral

Model confidence2/102 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 28.6 signals oversold conditions
  • Trading below the 200-day average of 1.75

Medium term

1–3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 28.6 signals oversold conditions
  • Trading below the 200-day average of 1.75

Long term

> 3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • Analyst targets imply +709.3% versus the current price
  • Negative return on equity of -99.0%
  • Revenue growth of +36.7%

Key metrics

Financial health

Revenue Growth36.70%
P/E Ratio-1.3
ROE-98.98%
ROA-27.86%
Debt/Equity10.66
P/B Ratio0.5
Op. Cash Flow$-46703000
Free Cash Flow$-30796000
Industry P/E31.0

Technical analysis

TrendBearish
RSI28.6
Support$0.50
Resistance$0.81
MA 20$0.64
MA 50$0.78
MA 200$1.75
MACDBearish
VolumeDecreasing
Fear & Greed Index91.3

Valuation

Target Price$4.13
Upside/Downside709.35%
GradeUndervalued
TypeBlend

Risk assessment

Beta1.43
Volatility99.09%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.